Defunct Company
Total Trials
5
As Lead Sponsor
As Collaborator
0
Total Enrollment
357
NCT01265914
A Study to Evaluate the Safety, Tolerability and Immunogenicity of a Universal Influenza A Vaccine
Phase: Phase 1
Role: Lead Sponsor
Start: Aug 31, 2010
Completion: Aug 31, 2011
NCT01677676
Safety, Tolerability and Immunogenicity of Two Different Formulations of an Influenza A Vaccine (FP-01.1)
Start: Jan 31, 2012
Completion: Sep 30, 2012
NCT01701752
Influenza A Vaccine (FP-01.1) Formulated With and Without Adjuvant, in the Presence or Absence of a Single Administration of a Trivalent Inactivated Influenza Virus Vaccine in Older Adults
Start: Sep 30, 2012
Completion: Apr 30, 2013
NCT02014870
Safety and Reactogenicity of a H1N1 Influenza Challenge Virus in Healthy Volunteers
Start: Jun 30, 2013
Completion: Oct 31, 2013
NCT02071329
Safety, Tolerability, Efficacy and Immunogenicity of an Influenza A Vaccine (FP-01.1) in Healthy Volunteers Following Virus Challenge
Phase: Phase 1/2
Start: Jan 31, 2014
Completion: Dec 31, 2014